We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SELX:NASDAQSemilux International Ltd. Analysis

Data as of 2026-06-11 - not real-time

$0.34

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Semilux International Ltd. (SELX) trades at roughly $0.34, dramatically below the DCF‑derived fair value of about $6.63, indicating a deep discount. However, the company is confronting a material regulatory event: Nasdaq has issued a Staff Determination Letter threatening delisting after the bid price stayed under $1 for 30 consecutive days. Technicals reinforce weakness – the 20‑day SMA (0.27) sits well under the 50‑day SMA (0.34) and 200‑day SMA (0.66), the 14‑day RSI is at 36.9 (oversold territory), and the MACD histogram is negative, all pointing to a bearish momentum. Financially, the firm posts negative gross (‑24%) and operating margins, a high debt‑to‑equity ratio exceeding 100%, and a ROE of ‑86%, while cash on hand barely covers its debt. Volatility is extreme at over 260% 30‑day, and beta of 0.87 suggests market‑linked swings. Given the confluence of regulatory pressure, deteriorating fundamentals, and bearish technical signals, short‑term exposure is highly risky.
Long‑term investors may view the massive valuation gap as a speculative upside opportunity if the company can resolve its listing issues, restructure debt, and return to profitability, but such a turnaround remains uncertain.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Nasdaq delisting notice
  • Bearish MACD and RSI below 40
  • Price below identified support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential resolution of listing issue
  • Extreme price volatility
  • Continued negative earnings and high leverage

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • DCF fair value suggests large upside
  • Possible strategic turnaround or restructuring
  • Industry exposure to high‑growth optical and AI applications

Key Metrics & Analysis

Financial Health

Revenue Growth-24.60%
Profit Margin-119.72%
ROE-86.63%
ROA-27.11%
Debt/Equity109.06
P/B Ratio2.1
Op. Cash Flow$4.0M
Free Cash Flow$23.4M
Industry P/E35.3

Technical Analysis

TrendBearish
RSI36.9
Support$0.15
Resistance$0.60
MA 20$0.27
MA 50$0.34
MA 200$0.66
MACDBearish
VolumeIncreasing
Fear & Greed Index83.38

Valuation

Fair Value$6.63
GradeUndervalued
TypeValue

Risk Assessment

Beta0.87
Volatility266.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.